Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$37.65 -2.37 (-5.92%)
As of 03:59 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$37.44
$39.66
50-Day Range
$38.05
$44.24
52-Week Range
$29.20
$44.31
Volume
3.87 million shs
Average Volume
3.25 million shs
Market Capitalization
$240.13 billion
P/E Ratio
N/A
Dividend Yield
2.26%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Remove Ads
Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Roche’s Genentech present data on trontinemab, Elecsys plasma test
EMA put clinical hold on Roche, Sarepta DMD studies after death
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the beginning of the year. Since then, RHHBY stock has increased by 7.9% and is now trading at $37.65.
View the best growth stocks for 2025 here
.

Roche subsidiaries include these companies: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more.

Top institutional shareholders of Roche include Boston Common Asset Management LLC (0.01%) and Confluence Investment Management LLC.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
13.40
P/E Growth
2.18
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$2.94 per share
Price / Cash Flow
12.82
Book Value
$5.81 per share
Price / Book
6.48

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$240.13 billion
Optionable
Not Optionable
Beta
0.48

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners